期刊文献+

神经节苷脂对糖尿病脑病患者认知功能的影响研究

Effect of Ganlioside on Cognitive Function of Patients with Diabetic Encephalopathy
在线阅读 下载PDF
导出
摘要 目的观察神经节苷脂对糖尿病脑病患者认知功能的影响。方法将我院2008年3月~2010年11月收治的52例糖尿病脑病患者随机分为两组,对照组25例采用常规疗法,观察组27例加用神经节苷脂,以简易精神状态检查量表(MMSE)评分、血清神经元特异性烯醇化酶(NSE)及S-100B蛋白为观察指标比较分析两组患者的认知功能。结果治疗前两组患者的MMSE评分、血清NSE及S-100B情况比较,差异均无统计学意义(P>0.05);治疗后两组患者的MMSE评分、血清NSE及S-100B情况均得到改善,以观察组改善更为明显,组间差异具有统计学意义(P<0.05)。结论神经节苷脂能够有效改善糖尿病脑病患者的认知功能,可能与其神经细胞保护作用有关。 Objective To discuss the effect of ganglioside on the cognitive function of the patients with diabetic encephalopathy.Methods 52 cases with diabetic encephalopathy hospitalized from Mar.,2008 to Nov.,2011 were randomly divided into 2 groups: observation group(n=27) and control group(n=25);routine treatment was applied to patients in both groups while ganlioside was added to patients in observation group;mini-mental state examination(MMSE) scores,serum neuron-specific enolase(NSE) and S-100B protein were taken as the observation indexes in comparing the cognitive function between the patients of the 2 groups.Results After treatment,the MMSE scores,serum NSE and S-100B protein of the patients in both groups were improved than those before treatment,and the improvement in observation group was more significant,the difference between the 2 groups was of statistical significance(P〈0.05).Conclusions Ganlioside can effectively improve the cognitive function of the patients with diabetic encephalopathy,which may be related to its protective effect of neurons.
作者 温艳 邓介华
出处 《西南军医》 2011年第6期984-985,共2页 Journal of Military Surgeon in Southwest China
关键词 糖尿病脑病 神经节苷脂 认知功能 简易精神状态检查量表 神经元特异性烯醇化酶 S-100B蛋白 diabetic encephalopathy ganglioside cognitive function mini-mental state examination neuron-specific enolase S-100B protein
  • 相关文献

参考文献10

二级参考文献118

  • 1范海虹,汪华侨.新生大鼠急性缺氧缺血性脑损伤时β-内啡呔的变化[J].中国民康医学,1999,0(2):25-27. 被引量:1
  • 2黄如彬,杨典洱,李爱华,潘颖,金有豫,贺建宇.急性重复性缺氧小鼠脑神经节苷脂含量的研究[J].生物化学与生物物理进展,1995,22(3):253-256. 被引量:5
  • 3胡志兵,戴建武,曹莹,李翠琼,朱慧芬.缺血性脑血管病患者糖尿病和糖调节异常的临床分析[J].中国脑血管病杂志,2007,4(1):14-17. 被引量:12
  • 4Piechwski-Jozwiak B,Maulaz A,Bogousslavskg J.Secondary prevention of stroke with antiplatelet agents in patients with diabetes mellitus[J].Cerebrovasc Dis,2005,20(1):15.
  • 5Crger PE,Davis SN,Shamoon H.Hgpoglycemia in diabetes[J].Diabetes Care,2003,26(9):1902.
  • 6[1]Biessels GJ,van der Heide LP,Kamnal A,et al.Ageing and diabetes:implications for brain function[J].Eur J Pharmacol,2002,441:1-14
  • 7[2]Fouyas IP,Kelly PA,Ritchie IM,et al.Cerebrovascular responses to pathophysiological insult in diabetic rats[J].J Clin Neurosci,2003,10:88-91
  • 8[3]Dai J,Vrensen GF,Schlingemann RO.Blood-brain barrier integrity is unaltered in human brain cortex with diabetes mellitus[J].Brain Res,2002,954:311-316
  • 9[4]Vlassara H,Palace MR.Glycoxidation:the menace of diabetes and aging[J].Mt Sinai J Med,2003,70:232-241
  • 10[5]Gispen WH,Biessels GJ.Cognition and synaptic plasticity in diabetes mellitus[J].Trends Neurosci,2000,23:542-549

共引文献234

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部